IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations

In the 2016, WHO classification of tumors of the central nervous system, isocitrate dehydrogenase (IDH) mutation is a main classifier for lower grade astrocytomas and IDH‐mutated astrocytomas is now regarded as a single group with longer survival. However, the molecular and clinical heterogeneity am...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Pathol
Autors principals: Yang, Rui Ryan, Shi, Zhi‐feng, Zhang, Zhen‐yu, Chan, Aden Ka‐Yin, Aibaidula, Abudumijiti, Wang, Wei‐wei, Kwan, Johnny Sheung Him, Poon, Wai Sang, Chen, Hong, Li, Wen‐cai, Chung, Nellie Yuk‐Fei, Punchhi, Gopika, Chu, William Ching‐Yuen, Chan, Ivan Sik‐Hei, Liu, Xian‐zhi, Mao, Ying, Li, Kay Ka‐Wai, Ng, Ho‐Keung
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018138/
https://ncbi.nlm.nih.gov/pubmed/31733156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12801
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars